Document Detail


A comparison of vasopressin and glucagon in beta-blocker induced toxicity.
MedLine Citation:
PMID:  16496493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We compared the efficacy of vasopressin and glucagon in a porcine model of beta-blocker toxicity. Our primary outcome was survival over 4 hours. METHODS: Sixteen pigs received a 1-mg/ kg bolus of propranolol IV followed by continuous infusion at 0.25 mg/kg/minute. Toxicity was defined as a 25% decrease in the product of heart rate (HR) and mean arterial pressure (MAP), at which point 20 mL/kg normal saline was rapidly infused. Each pig was randomly assigned to receive either vasopressin or glucagon after the saline bolus. The vasopressin group received a continuous infusion at 0.0028 U/kg/minute, titrated up to a maximum of 0.014 U/ kg/minute. The glucagon group received a 0.05-mg/kg bolus followed by continuous infusion at 0.15 mg/kg/hour. The HR, MAP, systolic BP (SBP), cardiac output (CO), glucose, and pH were monitored for 4 hours from toxicity or until death. RESULTS: One pig survived at 4 hours (vasopressin group). Analysis of the 4-hour Kaplan-Meier survival curves found no differences between the groups (log-rank test 0.059, p = 0.81). No overall differences were identified in MAP, systolic BP, cardiac output, glucose, pH, or HR. However, over the first hour MAP and SBP were significantly higher in the vasopressin group (p = 0.004, p = 0.006, respectively). CONCLUSION: In this beta-blocker toxicity model, there were no differences in the survival curves between vasopressin- and glucagon-treated pigs during a 4-hour analysis period. No overall differences were noted in MAP, systolic BP, CO, HR, pH, or glucose levels, although vasopressin treatment yielded higher MAP and systolic BP early in resuscitation.
Authors:
Joel S Holger; Kristin M Engebretsen; Christopher L Obetz; Tanya L Kleven; Carson R Harris
Related Documents :
1718213 - Use of intravenous gamma globulin to passively immunize high-risk children against resp...
8907133 - Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventr...
20013573 - Daptomycin use in a neonate: serum level monitoring and outcome.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical toxicology (Philadelphia, Pa.)     Volume:  44     ISSN:  1556-3650     ISO Abbreviation:  Clin Toxicol (Phila)     Publication Date:  2006  
Date Detail:
Created Date:  2006-02-24     Completed Date:  2006-03-14     Revised Date:  2009-11-17    
Medline Journal Info:
Nlm Unique ID:  101241654     Medline TA:  Clin Toxicol (Phila)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  45-51     Citation Subset:  AIM; IM    
Affiliation:
Department of Emergency Medicine, Regions Hospital, St. Paul, Minnesota 55101, USA. Joel.S.Holger@HealthPartners.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / poisoning*
Animals
Blood Pressure / drug effects
Disease Models, Animal
Glucagon / therapeutic use*
Heart Rate / drug effects
Hemodynamics / drug effects
Poisoning / drug therapy,  mortality,  physiopathology
Propranolol / poisoning*
Survival Rate
Swine
Vasoconstrictor Agents / therapeutic use*
Vasopressins / therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Vasoconstrictor Agents; 11000-17-2/Vasopressins; 525-66-6/Propranolol; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of oral calcium disodium EDTA on iron absorption in a human model of iron overdose.
Next Document:  The Leiden mutation and activated protein C resistance as risk factors for disseminated intravascula...